AssetMark Inc’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-9
Closed -$605 2382
2024
Q2
$605 Buy
+9
New +$606 ﹤0.01% 1906
2023
Q3
Sell
-60,535
Closed -$3.06M 1818
2023
Q2
$3.06M Buy
60,535
+2,303
+4% +$123K 0.01% 408
2023
Q1
$3.18M Sell
58,232
-5,888
-9% -$344K 0.01% 383
2022
Q4
$4.01M Sell
64,120
-10,542
-14% -$700K 0.02% 327
2022
Q3
$5.26M Buy
74,662
+3,045
+4% +$210K 0.02% 264
2022
Q2
$4.06M Buy
71,617
+12,506
+21% +$686K 0.02% 273
2022
Q1
$3.7M Buy
59,111
+28,009
+90% +$1.51M 0.02% 282
2021
Q4
$1.74M Buy
31,102
+29,531
+1,880% +$1.8M 0.01% 346
2021
Q3
$102K Buy
+1,571
New +$107K ﹤0.01% 646

Other funds holding AXNX

AssetMark Inc's AXNX Position: Q3 2024 in Review

AssetMark Inc sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2024, closing a stake of 9 shares — an estimated $605 sold.

AssetMark Inc first reported a position in AXNX in Q3 2021 and held it in 9 quarters. The position peaked at $5.26M in Q3 2022. 233 funds tracked by Wall St. Rank hold AXNX as of Q3 2024.

  • AssetMark Inc reported no remaining Axonics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • AssetMark Inc sold 9 Axonics, Inc. Common Stock shares in Q3 2024, an estimated $605.
  • AssetMark Inc first reported a position in Axonics, Inc. Common Stock in Q3 2021 and held it in 9 quarters.
  • AssetMark Inc's Axonics, Inc. Common Stock position peaked at $5.26M in Q3 2022.
  • 233 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2024.

Based on AssetMark Inc's 13F filing for Q3 2024, filed 1 Nov 2024.